Compare Deere & Company (DE) vs Teladoc Health Inc (TDOC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deere & Company vs Teladoc Health Inc — how do they compare? Deere & Company trades at $631.47 (market cap $175.95B), while Teladoc Health Inc trades at $5.68 (market cap $1.01B). The key difference: Deere & Company is far larger — about 174.2× Teladoc Health Inc's market cap, and Deere & Company pays a 0.99% dividend while Teladoc Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Deere & Company for 75 Days and Teladoc Health Inc for 39 Days on average.
| DE | TDOC | |
|---|---|---|
Market Cap | $175.95B | $1.01B |
Volume | 1,387,231 | 4,668,477 |
Sector | Industrials | Health |
52-Week High | $709.48 | $9.72 |
52-Week Low | $439.11 | $4.47 |
Typical Hold Time | 75 Days | 39 Days |
Enterprise Value | $229.85B | $1.27B |
Dividend Yield | 0.99% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Deere & Company (DE) trades at $656.87, down 3.8% on the day, showing near-term weakness despite strong earnings beats in recent quarters. The stock maintains a bullish analyst consensus with a $731.20 price target, representing 11% upside potential. Recent financial performance shows declining revenue from $60.2B in 2023 to $44.7B in 2025, though the company continues generating robust operating cash flow exceeding $7B annually. Technical indicators suggest bearish momentum with the stock trading below key resistance levels.
Deere presents a mixed investment case with attractive valuation upside but faces cyclical headwinds in agricultural equipment demand. The company's AI initiatives and dividend payments provide stability, while declining profit margins and elevated debt levels warrant caution. Wall Street remains optimistic with 43% buy ratings, though technical weakness suggests potential near-term pressure before fundamental strength prevails.
Teladoc Health (TDOC) trades at $5.67, showing modest daily gains but remains near multi-year lows with a bearish technical outlook. The company maintains strong revenue around $2.5B annually but continues to report net losses, with a -7.13% net margin in 2026. Recent management changes include the appointment of a new CFO, while analyst sentiment remains cautious despite a consensus price target of $8.83 representing 56% upside potential.
TDOC presents a high-risk opportunity with significant upside potential if the company can achieve profitability turnaround. The stock trades at discounted valuations (P/S 0.4x, P/B 0.77x) but faces execution risks from ongoing losses, BetterHelp segment challenges, and potential legal investigations. Free cash flow generation and integrated care growth provide stabilization, though sustained profitability remains the key catalyst needed for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deere & Company
Deere is the world's leading manufacturer of agricultural equipment, producing some of the most recognizable machines in the heavy machinery industry. The company is divided into four reportable segments: production and precision agriculture, small agriculture and turf, construction and forestry, and John Deere Capital. Its products are available through an extensive dealer network, which includes over 1,900 dealer locations in North America and approximately 3,700 locations globally. John Deere Capital provides retail financing for machinery to its customers, in addition to wholesale financing for dealers, which increases the likelihood of Deere product sales.
Read more on DE →About Teladoc Health Inc
Teladoc Health is a virtual health provider with a telehealth platform delivering 24-hour, on-demand healthcare via mobile devices, the internet, video, and phone. It also offers remote patient monitoring programs for chronic care management. Its platform connects members with a network of physicians and behavioral health professionals. Most of the company's revenue is generated from access fees on a subscription basis (per member, per month). The balance comes from visit fees and equipment rental and sales to hospital systems. Since inception, Teladoc has primarily partnered with employers, health plans, and health systems to offer network access to their members.
Read more on TDOC →
